CURA TOR Week ended 07 Aug 2026

Weekly Investor Report

Curaleaf Holdings, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data
Latest close 12.95 CAD
4.4% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 7.5% above the Trend Line and sits at 39.4% of its 52-week range. The latest completed week returned 4.4%, after a -4.1% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers. The latest news-sentiment score is 55/100.

Setup score 43 out of 100
Latest Close 12.95 CAD 7 Aug 2026
1W Return 4.4% latest completed week
4W Return -4.1% short-term follow-through
12W Return -8.0% quarterly tape
Trend Breadth 73.1% 38 of 52 weeks active
Volume Ratio 1.5x vs 13-week average
What is working
  • The trend backdrop is active with a 14-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 4.4% Latest completed week; four-week move -4.1%. Indicator stack 85/11 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 55/100 12 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 7.5% above the Trend Line and sits at 39.4% of its 52-week range. The latest completed week returned 4.4%, after a -4.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7412-week average 0.74

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership10/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.74Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.1% over four weeks, -8.0% over 12 weeks, and 54.2% over one year. The current trend has remained active for 14 consecutive weeks.

Performance by holding period

1W4.4%
4W-4.1%
12W-8.0%
26W32.0%
52W54.2%
Active trend streak14 weeks
Active weeks in one year38
Trend breadth73.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.56Latest activity-pressure read.
Pressure change-358.8%Four-week change in activity pressure.
Leadership-1.98Latest relative-leadership reading.
RS change-123.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 77%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength12/100Blend of value, momentum, and quality. Underlying universe rank 89; rank 1 is best.
Value9/100Relative valuation strength. Underlying universe rank 92; rank 1 is best.
Quality14/100Profitability and accounting quality. Underlying universe rank 87; rank 1 is best.
Momentum78/100Medium-term price momentum. Underlying universe rank 23; rank 1 is best.
Growth21/100Revenue and earnings growth. Underlying universe rank 80; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
2.7x
Market value relative to trailing revenue.
EV / EBITDA
18.4x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
1.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
49.6%
Gross profit retained from each unit of revenue.
Operating margin
1.7%
Operating profit retained from revenue.
Free-cash-flow margin
4.3%
Free cash flow generated from revenue.
Return on invested capital
1.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-5.0%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
10.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.0%
Net share repurchases relative to market value.
Shareholder yield
-0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment55/100

Weighted news tone is neutral across 12 relevant articles.

2 positive · 10 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-38.1%Distance below the 52-week high.
13-week volatility6.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+21.3%Week of 3 Apr.
Worst week-14.6%Week of 12 Jun.
Latest week+4.4%Week of 7 Aug.

Shape of recent returns

Strong gains7
Modest gains7
Flat weeks0
Modest losses5
Sharp losses7
Recent vol6.8%13-week weekly-return volatility.
Base vol12.1%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew9.7% / -8.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape46/100

Trend, activity pressure, participation, and risk combine to a 46/100 tape read.

 Indicator analysis78/100

Latest 12-week confirmation: trend 12/12, activity pressure 9/12, relative leadership 10/12.

Activity pressure 0.74; No reversal markers Factors25/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 70; Small Cap Core rank 86 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment55/100

Weighted news tone is neutral across 12 relevant articles.

Curaleaf Holdings (TSX:CURA) Stock Recovers As Profitability Meets Slower Growth Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202612.95 CAD4.4%12.05 CAD12.19 CAD-0.56-1.98989.6KOn
31 Jul 202612.41 CAD-4.2%11.97 CAD12.18 CAD-0.45-2.71778.0KOn
24 Jul 202612.96 CAD-1.4%11.91 CAD12.19 CAD-0.161.92487.6KOn
17 Jul 202613.14 CAD-2.7%11.86 CAD12.20 CAD0.064.49609.8KOn
10 Jul 202613.50 CAD-7.8%11.83 CAD12.20 CAD0.228.53689.1KOn
3 Jul 202614.65 CAD3.5%11.89 CAD12.21 CAD0.3219.3133.3KOn
26 Jun 202614.16 CAD0.7%11.78 CAD12.22 CAD0.4818.06224.2KOn
19 Jun 202614.06 CAD1.6%11.64 CAD12.21 CAD0.6319.15168.5KOn
12 Jun 202613.84 CAD-14.6%11.47 CAD12.19 CAD0.7319.29157.0KOn
5 Jun 202616.21 CAD11.4%11.30 CAD12.18 CAD0.9144.121.2MOn
29 May 202614.55 CAD5.0%11.13 CAD12.16 CAD0.9830.601.3MOn
22 May 202613.86 CAD-1.5%11.04 CAD12.14 CAD1.0327.68658.5KOn
15 May 202614.07 CAD-11.8%10.98 CAD12.12 CAD1.1634.231.6MOn
8 May 202615.96 CAD15.9%10.91 CAD12.10 CAD0.9453.871.5MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context